BioCurex, Inc.(fka BOCX)

[Ted F]

Gold, like I mentioned earlier, I always had little doubt that it was ABT that initiated the change in the license agreement. What is more evident now is that the notice was given in writing, since ABT has not bothered to finalize the agreement in principle (if they never formally sent a letter of intent of return the original agreement would still be in force, hence the 50K would still have to be paid). Thus ABT would not have left such loose ends unless they had taken the necessary steps to relieve themselves of any duties under the old agreement.

The million dollar question is-was BOCX required by the SEC to notify shareholders of the intent to return the license, or is this clouded by the negotiations to modify the agreement (which are still only in principal). I don't think that it would be very hard to prove that it was BOCX's intent to mislead investors by purposely taking the steps they did.